Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION (NDC 7377600111) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 2, 2026 , from http://ppman.hank.ai/transparency/procedure/7377600111/by-state?code_type=NDC
“LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION (NDC 7377600111) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/7377600111/by-state?code_type=NDC. Accessed
November 2, 2026 .
“LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION (NDC 7377600111) by State,” HANK Price Transparency ,
accessed November 2, 2026 ,
http://ppman.hank.ai/transparency/procedure/7377600111/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
7377600111 — Lifileucel 7.5 X 10exp9 To 72 X 10exp9 Cell Intravenous Suspension
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,608,022
National median
$918,870 – $2,297,175
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 7377600111 (NDC), with interquartile range
State Median p25 p75
PA $1,608,022 $918,870 $2,297,175